Search clinical trials for: Octreotide

Total 270 results

Juan A. Arnaiz

Unknown

Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial. (INFUTER)

Liver Cirrhosis Portal

Spain
NCIC Clinical Trials Group

Completed

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

Canada, United States
University of Warmia and Mazury
Stowarzyszenie Pacjentów i Osób Wspierających Chorych na Guzy Neuroendokrynne

Unknown

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression (POLNETS_PRRT)

Neuroendocrine Tumors

Poland
Carmen Schade-Brittinger

Completed

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Neuroendocrine Tumors

Germany
European Institute of Oncology

Completed

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe (RADIONET)

Neuroendocrine Tumors

Italy
Helsinki University Central Hospital

Completed

Impact of Pasireotide on Postoperative Pancreatic Fistulas Following Distal Resections

Surgical Complications
Stanford University
National Institute on Aging (NIA)

Completed

Stress, Diurnal Cortisol, and Breast Cancer Survival

Breast Cancer

United States
University of California, San Francisco
Peterson Family Foundation

Terminated

GA-68 DOTA-TOC of Somatostatin Positive Malignancies (DOTA-TOC)

Neuroendocrine Tumor | Neuroblastoma | Paraganglioma | Carcinoid Tumors

United States
University of Aarhus
Region MidtJylland Denmark

Completed

Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia

Obesity | Hypoglycemia | Surgery

Denmark
Cliniques universitaires Saint-Luc- Université...

Terminated

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation (SCIROCCO)

Neuroendocrine Tumors | Carcinoid Syndrome
Eli Lilly and Company

Completed

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

Carcinoma | Neuroendocrine Tumors

United States
Hadassah Medical Organization

Unknown

Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery

Fistula; Salivary Duct or Gland

Israel
Ipsen

Completed

Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

Acromegaly

Australia
Genentech, Inc.
Roche Pharma AG

Terminated

A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) (SCRIPT)

Rheumatoid Arthritis

United States, Belgium, Canada, Hungary, Argentina, Germany, Spain, Brazil, Poland, Israel, Mexico, Japan, France, Peru, Switzerland, Sweden, Italy, Australia, New Zealand, Panama, Czechia, Netherlands, Slovakia, Slovenia, Taiwan
Ipsen

Completed

A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide

Acromegaly

Spain, United Kingdom, Italy, France, Belgium, Hungary, Czechia, Denmark, Poland, Sweden
Novartis Pharmaceuticals

Terminated

Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer

Cancer

Czechia, Poland, Russian Federation, United Kingdom, Israel
General Hospital of Shenyang Military Region

Completed

Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage

Kidney Injury | Cirrhosis, Liver | Variceal Hemorrhage

China
Massachusetts General Hospital

Withdrawn

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Small Bowel Carcinoid Tumor

United States
Mahidol University

Unknown

Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic Drugs

Heart Diseases

Thailand
Ono Pharmaceutical Co. Ltd

Terminated

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Acromegaly

United States
Anna Cruceta

Withdrawn

Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

Fibrosis | Renal Failure | Hepatorenal Syndrome

Spain
Peking Union Medical College Hospital

Unknown

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Gastric NET

China
Lexicon Pharmaceuticals

Completed

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Carcinoid Syndrome

United States
Ipsen

Completed

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Gastroenteropancreatic Neuroendocrine Tumor

United States
The Second Hospital of Nanjing Medical University

Unknown

Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide

Post-ERCP Acute Pancreatitis | Epinephrine

China
Cedars-Sinai Medical Center
Novartis Pharmaceuticals

Completed

Ultrasound Guided Octreotide LAR Injection in Acromegaly

Acromegaly

United States
Xiangya Hospital of Central South University

Unknown

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Neuroendocrine Neoplasm

China
AdventHealth Translational Research Institute

Completed

Effects of Glucagon Administration on Energy Expenditure (GLEE)

Obesity | Hyperglucagonemia

United States
Radboud University Medical Center
St. Antonius Hospital

Unknown

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber (ROW)

Anemia | Gastrointestinal Hemorrhage | Hereditary Hemorrhagic Telangiectasia

Netherlands
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly (PAOLA)

Acromegaly

United States, Italy, Belgium, Saudi Arabia, Spain, France, Germany, Canada, United Kingdom, Colombia, Brazil, Israel, Turkey, Romania, Norway, Poland, Russian Federation, Argentina
Korea University

Completed

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding

Variceal Bleeding, Cirrhosis

Korea, Republic of
Arcispedale Santa Maria Nuova-IRCCS

Completed

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Neuroendocrine Tumours

Austria, Italy
Aspireo Pharmaceuticals Limited

Completed

Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.

Acromegaly
Aspireo Pharmaceuticals Limited

Completed

The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

Acromegaly
Chengfeng Wang

Unknown

The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial

Pancreatic Diseases

China
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Grupo Espanol de Tumores Neuroendocrinos

Completed

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET (EVERLAR)

Gastrointestinal Neoplasms

Spain
Camurus AB
Novartis

Completed

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Neuroendocrine Tumors | Acromegaly

Germany, Sweden, France, Italy
Theodor Bilharz Research Institute
Université Libre de Bruxelles

Completed

RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding

Variceal Hemorrhage

Egypt, Belgium
Sue O'Dorisio
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Dosimetry Guided PRRT With 90Y-DOTATOC

Medulloblastoma | Neuroblastoma | Meningioma | Neuroendrocrine Tumors
Mansoura University

Completed

Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy (PD)

Periampullary Carcinoma Resectable

Egypt
Chiasma, Inc.

Completed

Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

Acromegaly

United States, Netherlands, Italy, Serbia, Hungary, Germany, Lithuania, Mexico, Poland, Romania, Slovakia, Slovenia, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Acromegaly

United States, Germany, Italy, Belgium, Taiwan, Turkey, Switzerland, Israel, Netherlands, Sweden, United Kingdom, Korea, Republic of, Spain, France, Canada, Greece, Russian Federation, Denmark, Mexico, China, Hungary, Norway, Argentina and more
National Institute of Diabetes and Digestive and...

Completed

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Zollinger Ellison Syndrome | Islet Cell Adenoma

United States
Dauntless Pharmaceuticals

Completed

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Healthy Volunteer Study

United States
Lale Kostakoglu

Terminated

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
Sue O'Dorisio
National Cancer Institute (NCI); Ride for Kids

Withdrawn

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Recurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Untreated Childhood Brain Stem Glioma | Untreated Childhood Medulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma and other conditions

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)

Fungal Infections
Novartis Pharmaceuticals

Completed

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Thymoma

Germany

Search clinical trials for: Octreotide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations